Skip to content

Clinical trials

Phase 2 Respiration Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiration Disorders Phase: Phase 2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20106
20111
20131
20142
20171
20181
20191
20204
20211
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting2
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
GlaxoSmithKline4
Göteborg University2
Altesa Biosciences, Inc.1
Beyond Air Inc.1
Catalysis SL1
Centre d'Investigation Clinique et Technologique 8051
Columbia University1
Debiopharm International SA1
Northwestern University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiration Disorders27
Pulmonary Disease, Chronic Obstructive12
Lung Diseases7
Bronchiolitis Obliterans Syndrome4
COVID-193
Pulmonary Fibrosis3
Respiratory Tract Diseases3
Apnea2
Coronavirus Infections2
Emphysema2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.